Uzbekistan is set to offer enhanced subsidies and technology transfer incentives to attract greater investment from Indian pharmaceutical companies, according to Deputy Minister of Investment, Industry and Trade Shokhrukh Gulamov. The initiative aims to strengthen Uzbekistan's position as a regional hub for pharmaceutical manufacturing by simplifying regulatory approvals and providing tax incentives. Gulamov emphasized the importance of streamlined licensing procedures, reduced bureaucratic barriers, and predictable regulatory timelines to make local production more appealing. He also noted that access to industrial zones and joint ventures with local partners would enhance production capacity and compliance with quality standards. The partnership between India and Uzbekistan has been growing, with bilateral trade reaching $1.317 billion in 2025, a 33.3% increase from the previous year. As of May 2026, there are 397 Indian-invested enterprises in Uzbekistan, reflecting the increasing economic collaboration. Gulamov stressed that cultural diplomacy plays a significant role in strengthening these economic ties, enhancing trust and collaboration between the countries.